Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 366 entries
Sorted by: Best Match Show Resources per page
Assessing differences between university and federal laboratory postdoctoral scientists in technology transfer

postdoctoral

Choi H, Yoon H, Siegel D, Waldman DA, Mitchell MS.
GSID: ACszafM-P4MJ
H Choi, H Yoon, D Siegel, DA Waldman, MS Mitchell - Research Policy, 2022 - Elsevier

While there are numerous studies of university technology transfer, there have been relatively few studies of technology transfer at federal labs. Moreover, studies of university …

Cite
Choi, H., Yoon, H., Siegel, D., Waldman, D. A., & Mitchell, M. S. (2022). Assessing differences between university and federal laboratory postdoctoral scientists in technology transfer. Research Policy, 51(3), 104456.
Choi, Haneul, et al. "Assessing differences between university and federal laboratory postdoctoral scientists in technology transfer." Research Policy 51.3 (2022): 104456.
Copy Download .nbib Format: MLA
Seeing versus doing: two modes of accessing causal knowledge

Science interventions

Waldmann MR.
GSID: nkOKaQFif6MJ
MR Waldmann, Y Hagmayer - Journal of Experimental Psychology …, 2005 - psycnet.apa.org

The ability to derive predictions for the outcomes of potential actions from observational data is one of the hallmarks of true causal reasoning. We present four learning experiments with …

Cite
Waldmann, M. R., & Hagmayer, Y. (2005). Seeing versus doing: two modes of accessing causal knowledge. Journal of Experimental Psychology: Learning, Memory, and Cognition, 31(2), 216.
Waldmann, Michael R., and York Hagmayer. "Seeing versus doing: two modes of accessing causal knowledge." Journal of Experimental Psychology: Learning, Memory, and Cognition 31.2 (2005): 216.
Copy Download .nbib Format: MLA
Prevention of venous thromboembolism in the critically ill patient.

Journal of the Intensive Care Society

Achaibar K, Waldmann C.
PMID: 28979410
J Intensive Care Soc. 2015 Aug;16(3):199-201. doi: 10.1177/1751143715569404. Epub 2015 Jul 23.

No abstract available.

Cite
Achaibar K, Waldmann C. Prevention of venous thromboembolism in the critically ill patient. J Intensive Care Soc. 2015;16(3):199-201doi: 10.1177/1751143715569404.
Achaibar, K., & Waldmann, C. (2015). Prevention of venous thromboembolism in the critically ill patient. Journal of the Intensive Care Society, 16(3), 199-201. https://doi.org/10.1177/1751143715569404
Achaibar, Kira, and Waldmann, Carl. "Prevention of venous thromboembolism in the critically ill patient." Journal of the Intensive Care Society vol. 16,3 (2015): 199-201. doi: https://doi.org/10.1177/1751143715569404
Achaibar K, Waldmann C. Prevention of venous thromboembolism in the critically ill patient. J Intensive Care Soc. 2015 Aug;16(3):199-201. doi: 10.1177/1751143715569404. Epub 2015 Jul 23. PMID: 28979410; PMCID: PMC5606435.
Copy Download .nbib Format: NLM
Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs.

Cell reports

Illich DJ, Zhang M, Ursu A, Osorno R, Kim KP, Yoon J, Araúzo-Bravo MJ, Wu G, Esch D, Sabour D, Colby D, Grassme KS, Chen J, Greber B, Höing S, Herzog W, Ziegler S, Chambers I, Gao S, Waldmann H, Schöler HR.
PMID: 27149845
Cell Rep. 2016 Apr 26;15(4):787-800. doi: 10.1016/j.celrep.2016.03.073. Epub 2016 Apr 14.

It has previously been reported that mouse epiblast stem cell (EpiSC) lines comprise heterogeneous cell populations that are functionally equivalent to cells of either early- or late-stage postimplantation development. So far, the establishment of the embryonic stem cell (ESC)...

Cite
Illich DJ, Zhang M, Ursu A, et al. Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs. Cell Rep. 2016;15(4):787-800doi: 10.1016/j.celrep.2016.03.073.
Illich, D. J., Zhang, M., Ursu, A., Osorno, R., Kim, K. P., Yoon, J., Araúzo-Bravo, M. J., Wu, G., Esch, D., Sabour, D., Colby, D., Grassme, K. S., Chen, J., Greber, B., Höing, S., Herzog, W., Ziegler, S., Chambers, I., Gao, S., Waldmann, H., & Schöler, H. R. (2016). Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs. Cell reports, 15(4), 787-800. https://doi.org/10.1016/j.celrep.2016.03.073
Illich, Damir Jacob, et al. "Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs." Cell reports vol. 15,4 (2016): 787-800. doi: https://doi.org/10.1016/j.celrep.2016.03.073
Illich DJ, Zhang M, Ursu A, Osorno R, Kim KP, Yoon J, Araúzo-Bravo MJ, Wu G, Esch D, Sabour D, Colby D, Grassme KS, Chen J, Greber B, Höing S, Herzog W, Ziegler S, Chambers I, Gao S, Waldmann H, Schöler HR. Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs. Cell Rep. 2016 Apr 26;15(4):787-800. doi: 10.1016/j.celrep.2016.03.073. Epub 2016 Apr 14. PMID: 27149845; PMCID: PMC4850425.
Copy Download .nbib Format: NLM
Optical coherence tomography and visual evoked potentials in pediatric MS.

Neurology(R) neuroimmunology & neuroinflammation

Waldman AT, Liu GT, Lavery AM, Liu G, Gaetz W, Aleman TS, Banwell BL.
PMID: 28626779
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 05;4(4):e356. doi: 10.1212/NXI.0000000000000356. eCollection 2017 Jul.

OBJECTIVE: To determine the relative ability of optical coherence tomography (OCT) and pattern-reversal visual evoked potentials (pVEPs) to detect visual pathway involvement in pediatric-onset MS.METHODS: Pediatric-onset MS participants (onset 6 months) optic neuritis (ON) in one eye (8 participants)...

Cite
Waldman AT, Liu GT, Lavery AM, et al. Optical coherence tomography and visual evoked potentials in pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e356doi: 10.1212/NXI.0000000000000356.
Waldman, A. T., Liu, G. T., Lavery, A. M., Liu, G., Gaetz, W., Aleman, T. S., & Banwell, B. L. (2017). Optical coherence tomography and visual evoked potentials in pediatric MS. Neurology(R) neuroimmunology & neuroinflammation, 4(4), e356. https://doi.org/10.1212/NXI.0000000000000356
Waldman, Amy T, et al. "Optical coherence tomography and visual evoked potentials in pediatric MS." Neurology(R) neuroimmunology & neuroinflammation vol. 4,4 (2017): e356. doi: https://doi.org/10.1212/NXI.0000000000000356
Waldman AT, Liu GT, Lavery AM, Liu G, Gaetz W, Aleman TS, Banwell BL. Optical coherence tomography and visual evoked potentials in pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2017 Jun 05;4(4):e356. doi: 10.1212/NXI.0000000000000356. eCollection 2017 Jul. PMID: 28626779; PMCID: PMC5459791.
Copy Download .nbib Format: NLM
A Strongly Spin-Frustrated Fe(III) 7 Complex with a Canted Intermediate Spin Ground State of S=7/2 or 9/2.

Chemistry (Weinheim an der Bergstrasse, Germany)

Mondal KC, Mereacre V, Kostakis GE, Lan Y, Anson CE, Prisecaru I, Waldmann O, Powell AK.
PMID: 26073059
Chemistry. 2015 Jul 20;21(30):10835-42. doi: 10.1002/chem.201500841. Epub 2015 Jun 12.

A disk-shaped [Fe(III) 7 (Cl)(MeOH)6 (μ3 -O)3 (μ-OMe)6 (PhCO2 )6 ]Cl2 complex with C3 symmetry has been synthesised and characterised. The central tetrahedral Fe(III) is 0.733 Å above the almost co-planar Fe(III) 6 wheel, to which it is connected...

Cite
Mondal KC, Mereacre V, Kostakis GE, et al. A Strongly Spin-Frustrated Fe(III) 7 Complex with a Canted Intermediate Spin Ground State of S=7/2 or 9/2. Chemistry. 2015;21(30):10835-42doi: 10.1002/chem.201500841.
Mondal, K. C., Mereacre, V., Kostakis, G. E., Lan, Y., Anson, C. E., Prisecaru, I., Waldmann, O., & Powell, A. K. (2015). A Strongly Spin-Frustrated Fe(III) 7 Complex with a Canted Intermediate Spin Ground State of S=7/2 or 9/2. Chemistry (Weinheim an der Bergstrasse, Germany), 21(30), 10835-42. https://doi.org/10.1002/chem.201500841
Mondal, Kartik Chandra, et al. "A Strongly Spin-Frustrated Fe(III) 7 Complex with a Canted Intermediate Spin Ground State of S=7/2 or 9/2." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,30 (2015): 10835-42. doi: https://doi.org/10.1002/chem.201500841
Mondal KC, Mereacre V, Kostakis GE, Lan Y, Anson CE, Prisecaru I, Waldmann O, Powell AK. A Strongly Spin-Frustrated Fe(III) 7 Complex with a Canted Intermediate Spin Ground State of S=7/2 or 9/2. Chemistry. 2015 Jul 20;21(30):10835-42. doi: 10.1002/chem.201500841. Epub 2015 Jun 12. PMID: 26073059.
Copy Download .nbib Format: NLM
CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS.

BIOforum Europe : trends and techniques in life science research

Snook AE, Waldman SA.
PMID: 26855637
Bioforum Eur. 2009;3:14-16.

Employing antigens with expression restricted to normal intestinal mucosa and derivative colorectal tumors - cancer mucosa antigens (CMAs) - represents a novel paradigm in anti-tumor immunotherapy. Immune compartmentalization limits tolerance to CMAs and restricts mucosa-targeted autoimmunity, allowing safe and...

Cite
Snook AE, Waldman SA. CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS. Bioforum Eur. 2009;3:14-16
Snook, A. E., & Waldman, S. A. (2009). CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS. BIOforum Europe : trends and techniques in life science research, 314-16.
Snook, Adam E, and Waldman, Scott A. "CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS." BIOforum Europe : trends and techniques in life science research vol. 3 (2009): 14-16.
Snook AE, Waldman SA. CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS. Bioforum Eur. 2009;3:14-16. PMID: 26855637; PMCID: PMC4742354.
Copy Download .nbib Format: NLM
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

Oncoimmunology

Zhang Y, Tian S, Liu Z, Zhang J, Zhang M, Bosenberg MW, Kedl RM, Waldmann TA, Storkus WJ, Falo LD, You Z.
PMID: 25941586
Oncoimmunology. 2014 Dec 15;3(10):e959321. doi: 10.4161/21624011.2014.959321. eCollection 2014 Nov.

No abstract available.

Cite
Zhang Y, Tian S, Liu Z, et al. Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology. 2014;3(10):e959321doi: 10.4161/21624011.2014.959321.
Zhang, Y., Tian, S., Liu, Z., Zhang, J., Zhang, M., Bosenberg, M. W., Kedl, R. M., Waldmann, T. A., Storkus, W. J., Falo, L. D., & You, Z. (2014). Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology, 3(10), e959321. https://doi.org/10.4161/21624011.2014.959321
Zhang, Yi, et al. "Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency." Oncoimmunology vol. 3,10 (2014): e959321. doi: https://doi.org/10.4161/21624011.2014.959321
Zhang Y, Tian S, Liu Z, Zhang J, Zhang M, Bosenberg MW, Kedl RM, Waldmann TA, Storkus WJ, Falo LD, You Z. Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology. 2014 Dec 15;3(10):e959321. doi: 10.4161/21624011.2014.959321. eCollection 2014 Nov. PMID: 25941586; PMCID: PMC4292719.
Copy Download .nbib Format: NLM
Dickkopf-3, a tissue-derived modulator of local T-cell responses.

Frontiers in immunology

Meister M, Papatriantafyllou M, Nordström V, Kumar V, Ludwig J, Lui KO, Boyd AS, Popovic ZV, Fleming TH, Moldenhauer G, Nawroth PP, Gröne HJ, Waldmann H, Oelert T, Arnold B.
PMID: 25759692
Front Immunol. 2015 Feb 24;6:78. doi: 10.3389/fimmu.2015.00078. eCollection 2015.

The adaptive immune system protects organisms from harmful environmental insults. In parallel, regulatory mechanisms control immune responses in order to assure preservation of organ integrity. Yet, molecules involved in the control of T-cell responses in peripheral tissues are poorly...

Cite
Meister M, Papatriantafyllou M, Nordström V, et al. Dickkopf-3, a tissue-derived modulator of local T-cell responses. Front Immunol. 2015;6:78doi: 10.3389/fimmu.2015.00078.
Meister, M., Papatriantafyllou, M., Nordström, V., Kumar, V., Ludwig, J., Lui, K. O., Boyd, A. S., Popovic, Z. V., Fleming, T. H., Moldenhauer, G., Nawroth, P. P., Gröne, H. J., Waldmann, H., Oelert, T., & Arnold, B. (2015). Dickkopf-3, a tissue-derived modulator of local T-cell responses. Frontiers in immunology, 678. https://doi.org/10.3389/fimmu.2015.00078
Meister, Michael, et al. "Dickkopf-3, a tissue-derived modulator of local T-cell responses." Frontiers in immunology vol. 6 (2015): 78. doi: https://doi.org/10.3389/fimmu.2015.00078
Meister M, Papatriantafyllou M, Nordström V, Kumar V, Ludwig J, Lui KO, Boyd AS, Popovic ZV, Fleming TH, Moldenhauer G, Nawroth PP, Gröne HJ, Waldmann H, Oelert T, Arnold B. Dickkopf-3, a tissue-derived modulator of local T-cell responses. Front Immunol. 2015 Feb 24;6:78. doi: 10.3389/fimmu.2015.00078. eCollection 2015. PMID: 25759692; PMCID: PMC4338807.
Copy Download .nbib Format: NLM
Companion diagnostics at the intersection of personalized medicine and healthcare delivery.

Biomarkers in medicine

Waldman SA, Terzic A.
PMID: 25605449
Biomark Med. 2015;9(1):1-3. doi: 10.2217/bmm.14.99.

No abstract available.

Cite
Waldman SA, Terzic A. Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomark Med. 2015;9(1):1-3doi: 10.2217/bmm.14.99.
Waldman, S. A., & Terzic, A. (2015). Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomarkers in medicine, 9(1), 1-3. https://doi.org/10.2217/bmm.14.99
Waldman, Scott A, and Terzic, Andre. "Companion diagnostics at the intersection of personalized medicine and healthcare delivery." Biomarkers in medicine vol. 9,1 (2015): 1-3. doi: https://doi.org/10.2217/bmm.14.99
Waldman SA, Terzic A. Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomark Med. 2015;9(1):1-3. doi: 10.2217/bmm.14.99. PMID: 25605449; PMCID: PMC5533276.
Copy Download .nbib Format: NLM
Asymmetric Synthesis of the Nakijiquinones-Selective Inhibitors of the Her-2/Neu Protooncogene.

Angewandte Chemie (International ed. in English)

Stahl P, Waldmann H.
PMID: 10649333
Angew Chem Int Ed Engl. 1999 Dec 16;38(24):3710-3713.

A Wieland-Miescher type ketone and a tetramethoxyaryl derivative are the key building blocks for the enantioselective total synthesis of nakijiquinone C (1). The nakijiquinones are the only natural products known that selectively inhibit the Her-2/Neu tyrosine kinase, a protooncogene...

Cite
Stahl P, Waldmann H. Asymmetric Synthesis of the Nakijiquinones-Selective Inhibitors of the Her-2/Neu Protooncogene. Angew Chem Int Ed Engl. 1999;38(24):3710-3713
Stahl, P., & Waldmann, H. (1999). Asymmetric Synthesis of the Nakijiquinones-Selective Inhibitors of the Her-2/Neu Protooncogene. Angewandte Chemie (International ed. in English), 38(24), 3710-3713.
Stahl, and Waldmann. "Asymmetric Synthesis of the Nakijiquinones-Selective Inhibitors of the Her-2/Neu Protooncogene." Angewandte Chemie (International ed. in English) vol. 38,24 (1999): 3710-3713.
Stahl P, Waldmann H. Asymmetric Synthesis of the Nakijiquinones-Selective Inhibitors of the Her-2/Neu Protooncogene. Angew Chem Int Ed Engl. 1999 Dec 16;38(24):3710-3713. PMID: 10649333.
Copy Download .nbib Format: NLM
Chiral bicyclic phosphoramidites--a new class of ligands for asymmetric catalysis.

Chemistry (Weinheim an der Bergstrasse, Germany)

Huttenloch O, Spieler J, Waldmann H.
PMID: 11261665
Chemistry. 2001 Feb 02;7(3):671-5. doi: 10.1002/1521-3765(20010202)7:3<671::aid-chem671>3.0.co;2-m.

The development of new ligands for catalytic asymmetric C-C bond formation is of great interest to organic synthesis. We describe here a new class of chiral phosphoramidites that embody one or two binaphthol units attached to an achiral azabicyclic...

Cite
Huttenloch O, Spieler J, Waldmann H. Chiral bicyclic phosphoramidites--a new class of ligands for asymmetric catalysis. Chemistry. 2001;7(3):671-5doi: 10.1002/1521-3765(20010202)7:3<671::aid-chem671>3.0.co;2-m.
Huttenloch, O., Spieler, J., & Waldmann, H. (2001). Chiral bicyclic phosphoramidites--a new class of ligands for asymmetric catalysis. Chemistry (Weinheim an der Bergstrasse, Germany), 7(3), 671-5. https://doi.org/10.1002/1521-3765(20010202)7:3<671::aid-chem671>3.0.co;2-m
Huttenloch, O, et al. "Chiral bicyclic phosphoramidites--a new class of ligands for asymmetric catalysis." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 7,3 (2001): 671-5. doi: https://doi.org/10.1002/1521-3765(20010202)7:3<671::aid-chem671>3.0.co;2-m
Huttenloch O, Spieler J, Waldmann H. Chiral bicyclic phosphoramidites--a new class of ligands for asymmetric catalysis. Chemistry. 2001 Feb 02;7(3):671-5. doi: 10.1002/1521-3765(20010202)7:3<671::aid-chem671>3.0.co;2-m. PMID: 11261665.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 366 entries